Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Startup Commercializes Engineered Tissue to Transform Medical Device Tech

January 7, 2019 By University of Minnesota

University of Minnesota Technology Commercialization announced the formal launch of Vascudyne Inc., a startup company based in Stillwater, Minn., focused on the development of biologically engineered tissue for medical device and therapeutics applications. The technology offers a regenerative capacity unavailable until now in materials and devices used for medical treatment.

Vascudyne’s technology is based on discoveries by University researcher Robert Tranquillo, Ph.D., professor in the departments of Biomedical Engineering and Chemical Engineering & Materials Science in the College of Science and Engineering, and researchers in his lab, Zeeshan Syedain, Ph.D., senior research associate, and Lee Meier, B.S., staff scientist and present MD/Ph.D. student.

Vascudyne Engineered Tissue is based on decellularized collagenous tissue grown in a simple bioreactor from human dermal fibroblasts in fibrin gel. The resulting tissue has biological and mechanical properties very similar to native tissue and should regenerate and grow with the patient based on preclinical studies. This completely biological, off-the-shelf biomimetic material has the potential to move medical device technologies beyond the supply, durability, and hemocompatibility limitations of current synthetic and native tissue options.

“We are excited about the prospects of this material grown from skin cells becoming a clinical reality with its commercialization by Vascudyne,” said Tranquillo, “given its success in our preclinical studies and its potential as a platform technology for many applications.”

The technology was recently awarded several patents and successfully used in University preclinical studies as a heart valve and a vascular graft, which demonstrated unprecedented somatic growth. The vascular graft studies were published in Nature Communications and Science Translational Medicine.  

“The need for cardiovascular replacement parts has never been greater, and this need is expected to grow significantly in the near future,” said Luke Brewster, MD, Ph.D., assistant professor of surgery in Division of Vascular Surgery at the Emory University School of Medicine, who was not involved in developing the technology. “Biologically compatible replacement tissue for cardiovascular disease is the Holy Grail for patients and clinicians, who have not seen a full step forward in these technologies since the 1950s. Professor Tranquillo’s innovative cardiovascular tissue platform is well positioned to help the field take this important step into the future.”

Vascudyne has completed Phase I of its technology plan, the translation of the technology from the University setting to its Stillwater facility, and has implemented pilot-scale manufacturing capable of producing engineered tissue to support preclinical animal studies and first-in-human clinical trials.

Vascudyne plans to initially pursue two products utilizing the University-developed engineered tissue: a new generation of small-diameter vascular conduits and a transcatheter-delivered valve intended for right-side heart applications. Both projects are in planning for preclinical studies in 2019, to be followed by regulatory submissions for early clinical trials.

Next, the company will continue optimizing and growing its operations while implementing this material into novel medical device designs. For this work, Vascudyne is offering limited opportunities for commercial clients to pursue this novel material in their own medical device technology. 

Related Articles Read More >

A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
This is a Phillips Medisize marketing image of
Phillips Medisize launches TheraVolt medical connectors
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
An image of the Abbott Volt PFA System catheter and cart, which helps physicians visualize the location and effectiveness of cardiac ablation.
Abbott’s Volt PFA system isn’t just a catheter and a waveform
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe